Viewing Study NCT05918302


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-15 @ 1:47 PM
Study NCT ID: NCT05918302
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None Lung Neuroendocrine Neoplasm View
None Thymus Neoplasms View
Keywords: